Insider · CIK 0001951287
Eric Karas
Files at SPRY (ARS Pharmaceuticals, Inc.). First filing Dec 4, 2024, latest Jul 3, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SPRY: ARS Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | ARS Pharmaceuticals, Inc. | $255k 15,000 shares | -59% | +58% from low-12% from high | |
| 21Weak | ARS Pharmaceuticals, Inc. | $240k 15,000 shares | -66% | +56% from low-9% from high | |
| 11Weak | ARS Pharmaceuticals, Inc. | $140k 10,000 shares | -57% | +41% from low-18% from high | |
| 26Weak | ARS Pharmaceuticals, Inc. | $140k 10,000 shares | -106% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +15,000 | $1.50 | $23k | 25,315 | Jul 3, 2025 |
| Jul 1, 2025 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.99 | $255k | 10,315 | Jul 3, 2025 |
| Jul 1, 2025 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 544,588 | Jul 3, 2025 |
| Jun 18, 2025 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +15,000 | $1.50 | $23k | 22,696 | Jun 20, 2025 |
| Jun 18, 2025 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.00 | $240k | 7,696 | Jun 20, 2025 |
| Jun 18, 2025 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 559,588 | Jun 20, 2025 |
| Mar 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $1.50 | $15k | 17,696 | Mar 21, 2025 |
| Mar 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $14.00 | $140k | 7,696 | Mar 21, 2025 |
| Mar 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 574,588 | Mar 21, 2025 |
| Jan 2, 2025 | SPRY ARS Pharmaceuticals, Inc. | AGrant or award Stock option (right to buy)derivative | +152,300 | $0.00 | $0 | 152,300 | Jan 3, 2025 |
| Dec 2, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +3,717 | $1.50 | $5,576 | 9,410 | Dec 4, 2024 |
| Dec 2, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -3,717 | $14.11 | $52k | 5,693 | Dec 4, 2024 |
| Dec 4, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +6,283 | $1.50 | $9,425 | 11,976 | Dec 4, 2024 |
| Dec 4, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -6,283 | $14.00 | $88k | 5,693 | Dec 4, 2024 |
| Dec 2, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,717 | $0.00 | $0 | 590,871 | Dec 4, 2024 |
| Dec 4, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,283 | $0.00 | $0 | 584,588 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.